Skip to main content
The Journal of Clinical Hypertension logoLink to The Journal of Clinical Hypertension
. 2007 May 25;7(3):165–172. doi: 10.1111/j.1524-6175.2005.04079.x

Dietary Influences on Blood Pressure: The Effect of the Mediterranean Diet on the Prevalence of Hypertension

Peter Kokkinos 1, Demosthenes B Panagiotakos 2, Evangelos Polychronopoulos 2
PMCID: PMC8109559  PMID: 15785158

Abstract

Hypertension has long been recognized as a major risk factor for several common cardiovascular diseases. The World Health Organization reports that the number of people with hypertension worldwide is estimated at 600 million, while 3 million will die annually as a result of hypertension. There is evidence to support that several factors related to lifestyle habits may influence blood pressure levels. Among these, the beneficial effect of diet on human health, as well as on the control of hypertension, has been underlined in several studies. Moreover, adherence to a Mediterranean diet has been associated with reduced all‐cause mortality and, especially, coronary heart disease. The effect of this traditional diet on blood pressure levels has not been well understood and appreciated. This review summarizes the current understanding of the dietary influences on blood pressure control and the findings of observational and clinical studies that have evaluated the effect of the Mediterranean dietary pattern on the prevalence of chronic essential hypertension.


Chronic essential hypertension is a major risk factor for cardiovascular (CV) disease, including coronary heart disease (CHD), cerebrovascular disease, and heart failure, as well as a major health problem for industrialized societies. The World Health Organization reports that the number of people with hypertension worldwide is estimated at 600 million, of whom 3 million will die annually as a result of hypertension. It is also estimated that in the United States, only about one third of people with hypertension achieve blood pressure (BP) control. 1 , 2 , 3 Positive lifestyle modifications may potentially contribute to the prevention of chronic hypertension as well as the normalization of elevated BP. 3

Among these lifestyle modifications, the beneficial effect of diet has been emphasized in several studies. 4 , 5 , 6 , 7 The National High Blood Pressure Education Program 3 suggests nonpharmacologic interventions, such as diet, weight loss, and physical activity for the primary and secondary prevention of hypertension. There is increasing scientific evidence of the protective health effects of diets that are high in fruits, vegetables, legumes, and whole grains, and also include fish, nuts, and low‐fat dairy products. Such diets need not be restricted in total lipid intake as long as energy intake does not exceed expenditure, and the emphasis is on vegetable oils that are low in saturated fats and partially hydrogenated oils. The traditional Mediterranean diet, whose principal source of dietary lipids is olive oil, includes these dietary characteristics. 7 , 8 In recent decades, a large body of evidence has related adherence to a Mediterranean diet to to a lower allcause mortality, as well as a lower incidence of CHD and certain types of cancer. 9 , 10 , 11 In this review, we summarize the nutritional guidance for BP control, and the findings of observational studies that evaluated the effect of comprehensive dietary approaches, i.e., the Dietary Approaches to Stop Hypertension (DASH) 6 diet and the Mediterranean diet, in the prevention of chronic hypertension.

DIET AND HYPERTENSION

Current recommendations from the National High Blood Pressure Education Program 3 suggest weight control, reduction of sodium and alcohol intake, and an increase in potassium and magnesium consumption.

Sodium Intake

Increased fluid volume as a consequence of excess sodium intake has received much attention. A number of investigators believe that excess sodium intake contributes to the occurrence of hypertension (BP >140/90 mm Hg). 12 A rise in BP is seen when people on low‐salt diets with normal BP adopt Western lifestyles and increase their intake of sodium 13 ; however, confounding factors such as the lower incidence of obesity, high levels of physical activity, and perhaps a less stressful lifestyle in these populations were not considered in these studies. Most experimental studies indicate that sodium restriction in hypertensive patients decreases BP. 13 , 14 The Trials of Hypertension Prevention, 15 a randomized controlled study, also showed that individuals with high–normal BP who restricted sodium intake moderately for 1.5–5 years had lower BP and a lower incidence of hypertension than those who did not change sodium intake. Although epidemiologic and experimental findings support the role of excess sodium intake in hypertension, only half of the population in Western societies, where high sodium consumption is prevalent, develop hypertension. This suggests that some may have a sensitivity to sodium or that sodium excretion may be impaired. Impairment of renal sodium excretion is supported by experimental studies in rats bred to be salt‐sensitive or resistant to the hypertensive action of increased dietary sodium intake. When the kidney from a normotensive rat is transplanted to a hypertensive rat, BP decreases to normal. Conversely, when a normotensive rat receives a kidney from a hypertensive rat, BP increases. 16

Impairment in sodium excretion at the tubular level may contribute to hypertension. Some investigators have proposed that sodium retention leads to water retention and an increase in blood volume. This, in turn, increases cardiac output resulting in higher BP. 17 Others have argued that excess sodium may increase sympathetic activity which, in turn, will enhance vasoconstriction. 18 The role of sodium in the pathogenesis of hypertension is still being debated. Most recently, in a meta‐analysis that included 56 randomized, controlled trials, Midgley et al. 19 concluded that dietary sodium restriction may provide some benefits for hypertensive individuals over the age of 45 years; however, normotensive individuals may have nothing to gain from limiting sodium intake. These findings were corroborated by the Trial of Hypertension Prevention‐II (TOHPII), 20 the largest and longest study ever executed to assess the role of sodium restriction on BP control and the prevention of hypertension.

Potassium Intake

Evidence from population studies and clinical trials suggests a weak inverse association between estimates of potassium intake and BP; low potassium intake may increase BP. 21 , 22 The effect appears to be more pronounced in individuals exposed to high dietary sodium intake. The hemodynamic effects of potassium may be linked to potassium‐mediated sodium excretion (distal tubular effect). 22 Potassium supplementation may be therapeutic in the treatment of hypertension in some patients; however, the risk of hyperkalemia for subgroups of patients should be considered, and large doses of potassium should be avoided.

Magnesium Intake

Epidemiologic studies suggest an inverse relationship between BP and dietary magnesium; however, well‐designed, randomized trials are few and their findings are inconsistent. 23 , 24 These studies suggest that BP reduction with supplemental magnesium may occur only in patients with baseline low magnesium levels. Intracellular concentrations of magnesium may play a key role in regulating vascular tone and insulin‐mediated glucose uptake. 24 It is further postulated that reduced levels of intracellular magnesium may explain the association between insulin resistance and hypertension.

Calcium Intake

Epidemiologic evidence suggests an increased prevalence of hypertension with a low dietary calcium intake. 25 The theoretical basis for the role of calcium in the pathogenesis of hypertension is provided by the central role calcium plays in the modulation of vascular smooth muscle contraction. Alterations in smooth muscle contraction resulting from abnormalities in calcium metabolism may ultimately increase peripheral resistance and therefore increase BP. Most, but not all, studies observed reductions in BP with oral calcium supplementation in hypertensive patients. 26 Two recent meta‐analyses of randomized controlled calcium supplementation trials have identified a small, but consistent, reduction in BP in normotensive and hypertensive subjects who increased their calcium consumption. For an average calcium intake from 0.5–2.0 g/d, the authors observed a 0.53 mm Hg decrease for systolic BP in subjects with normal BP and a 1.68 mm Hg decrease for systolic BP in subjects with hypertension; however, the modest reduction in systolic BP identified by these meta‐analyses do not justify the use of calcium supplementation for BP control in hypertensive patients. 27 , 28

Alcohol Intake

Epidemiologic findings have provided conflicting reports on the association of alcohol consumption and BP. In one study, subjects who drank daily had higher BP levels than heavy weekend drinkers, while in another study, a J‐shaped association between alcohol consumption and BP, as well as CV risk, was observed. 29 , 30 , 31 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 3 identifies excessive alcohol consumption (e.g., more than 4–5 drinks of whiskey per day) as a risk for hypertension and stroke; this degree of use may cause resistance to antihypertensive medication. It is estimated that alcohol‐related hypertension may account for as much as 30% of cases of essential hypertension. 3 This, and the high prevalence of alcohol consumption in several cultures, makes alcohol consumption a considerable, but modifiable, risk factor for hypertension. Thus, efforts to implement lifestyle changes in the prevention and treatment of hypertension should include abstention from, or at least moderation of, alcohol consumption.

COMPREHENSIVE DIETARY CHANGES

For decades, public policy recommendations regarding dietary approaches in the management of hypertension have emphasized restrictions of sodium. 7 However, recent research suggests that comprehensive dietary changes other than sodium restriction alone play a more important role in the etiology, prevention, and treatment of hypertension. 32

The Mediterranean Diet

Clinical trials report lower BPs in vegetarians than in non‐vegetarians and people with diets rich in minerals and fiber 33 ; however, vegetarian diets are not practical for most people. An alternative to a vegetarian diet is the Mediterranean diet. 34 , 35 Olive oil is the most important element in this diet, not only because it has several beneficial properties, but also because it encourages the consumption of large quantities of vegetables in the form of salads and equally large quantities of legumes in the form of cooked foods. This is perhaps the single most important difference between the Mediterranean diet and the new dietary guidelines proposed by the Center for Nutrition Policy and Promotion at the United States Department of Agriculture. 36 Other essential components of the Mediterranean diet are wheat, olives, grapes, and their various derivative products. This traditional diet may be thought of as having nine components: high consumption of olive oil, legumes, cereals, fruits, vegetables; moderate‐to‐high consumption of fish; moderate consumption of wine, dairy products (mostly as cheese and yogurt), and beans; and a low consumption of meat and meat products. Alcohol is consumed in moderation and almost always during meals. This diet is low in saturated fat (less than 9% of energy), with total lipid intake ranging from <30% to >40% of energy from one area to another. Moreover, the ratio of monounsaturated to saturated fats is about 2:1, which is higher than in the usual diet in the United States.

The high content of vegetables, fresh fruits, and cereals, and the liberal use of olive oil in the Mediterranean diet guarantees an adequate intake of beta carotene, vitamin C, tocopherols, linolenic acid, various important minerals, and several possibly beneficial non‐nutrient substances such as polyphenols and anthocyanins. The Mediterranean diet can be represented in the form of a triangle (pyramid), the base of which refers to foods which are to be consumed most frequently and the top to those to be consumed rarely, with the remaining foods occupying intermediate positions. 37 Compared with the US Food Guide Pyramid from the United States Department of Agriculture, 36 the Mediterranean diet includes less meat, less saturated fats, and more fruits and vegetables.

The Epidemiologic Evidence. Epidemiological data have provided evidence that the health status of Mediterranean populations may have benefited from this specific diet. Although interpretations of these data are difficult, a potential explanation of the lower CV mortality rates among Mediterranean populations is their traditional diet, as suggested by the Seven Countries Study. 9 The investigators—based on the two Greek cohorts of Corfu and Crete—reported the protective role of the Mediterranean diet against atherosclerosis, mainly due to lower levels of BP and body mass index. Many years later, the CARDIO2000 investigators 38 studied a sample of approximately 2000 middle‐aged patients with a first myocardial infarction or unstable angina and matched by age and sex from various Greek regions. They reported that the adoption of a Mediterranean diet was related to an adjusted 7%–10% reduction in the coronary risk in treated, untreated, or uncontrolled hypertensive subjects. Recently, in a large prospective survey involving 22,043 middle‐age and older adults from Greece, Trichopoulou and colleagues 39 from the Greek cohort of the European Prospective Investigation Into Cancer and Nutrition (EPIC) study reported that an inverse association with greater adherence to the Mediterranean diet was observed for death due to CHD, irrespective of gender, smoking status, level of education, body mass index, and level of physical activity. Martinez‐Gonzalez et al., 10 in a case‐control study that included about 350 patients and controls, reported that the higher the Mediterranean diet score, the lower the odds ratio of myocardial infarction, mainly due to lower BP levels, after adjustment for other CV risk factors. Schroder et al., 40 studying a Mediterranean population in Spain, emphasized the importance of diet and sodium intake as a nonpharmacologic approach in the prevention and treatment of essential hypertension.

In other studies, Alonso et al., 41 in a crosssectional analysis of 4393 participants in Spain, observed that a high fruit and vegetable intake was inversely associated with BP levels in a population with a high fat consumption. Comparing those in the highest quintile of both fruit and vegetable consumption with those in the lowest quintile of both food groups, the odds ratio of hypertension was 0.23 (0.10–0.55) after adjusting for other risk factors and other dietary exposures. Ruiz‐Gutierrez et al. 42 studied the effect of a diet rich in monounsaturated fatty acids from high‐oleic sunflower oil and olive oil on BP levels in hypertensive women. They observed a significant reduction in systolic and diastolic BPs after the ingestion of olive oil. Finally, Strazzulo et al. 43 observed that a decrease in the saturated fatty acid content of the diet with a moderate change in the ratio of dietary polyunsaturated to saturated fat significantly reduced BP levels.

APathophysiologicExplanation. The Mediterranean diet is low in saturated fat and high in monounsaturated fat (mainly from olive oil), high in complex carbohydrates from legumes, and high in fiber (mostly from vegetables and fruits). Total fat is high, i.e., about 40% of total energy intake, but the ratio of monounsaturated to saturated fat is approximately 2:1. The high content of vegetables, fruits, cereals, and olive oil guarantees a high intake of beta carotene, vitamins C and E, polyphenols, and various important minerals. These key elements have been suggested to explain the beneficial effect of diet on human health, and especially CV disease. 34 , 35 , 39 , 44 Simopoulos 45 suggests that the Mediterranean dietary pattern includes a number of protective substances such as selenium, glutathione, a balanced ratio of (n‐6):(n‐3) essential fatty acids, high amounts of fiber, antioxidants (especially resveratrol from wine and polyphenols from olive oil), as well as vitamins E and C, which may be associated with a lower risk of hypertension, CHD, and cancer.

DIETARY APPROACHES TO STOP HYPERTENSION (DASH)

The Dietary Approaches to Stop Hypertension (DASH) clinical trial 6 lends support to a comprehensive dietary intervention similar to that of the Mediterranean diet. This study enrolled 459 adults with systolic BPs of <160 mm Hg and diastolic BPs 80–95 mm Hg. At first, the subjects were fed a control diet that was low in fruits, vegetables, and dairy products, and a diet that has a fat content typical of the average US diet. Then they were randomly assigned to receive: 1) the control diet; 2) a diet rich in fruits and vegetables; or 3) a “combination” diet rich in fruits, vegetables, and low‐fat dairy products with reduced saturated and total fat. The objective of this study was to assess whether a diet rich in fruits, vegetables, and lowfat dairy foods, with sodium held constant, could substantially lower BP. The “combination” diet was associated with 5.5 mm Hg and 3.0 mm Hg lower systolic and diastolic BPs, respectively, than the control diet (p<0.001), while the fruits‐and‐vegetables diet reduced systolic BP by 2.8 mm Hg more (p<0.001) than the control diet. Among the 133 subjects with hypertension, moreover the combination diet reduced systolic and diastolic BP by 11.4 mm Hg and 5.5 mm Hg more, respectively, than the control diet (p<0.001 for each). Among the 326 subjects without hypertension, the corresponding reductions were 3.5 mm Hg (p<0.001) and 2.1 mm Hg (p=0.003). 6 All of these findings strongly suggest that the focus of dietary changes for the control of BP should not be on a single nutrient alone. A low‐fat diet rich in fruits and vegetables and adequate intake of calcium, magnesium, and potassium should be recommended.

Diet and nutrition have been extensively investigated as risk factors for major CV diseases and are also linked to other metabolic diseases, such as diabetes, high BP, and obesity. There is now evidence that an adequate intake of fruits and vegetables, olive oil, fiber, and moderate alcohol are protective against hypertension. Sufficient knowledge exists to suggest that composite diets like the DASH diet or the Mediterranean diet may reduce the risk of hypertension and, consequently, CHD. De Lorgeril and Salen 46 suggest that in addition to its gastronomic appeal, the cardioprotective effects of the Mediterranean diet—with a reduction of blood lipids and BP levels—makes this dietary pattern attractive for public health purposes. Kouris‐Blazos et al. 47 suggest that the Mediterranean dietary pattern can easily be translated into other cultures; other food options can be employed to increase the intake of monounsaturated fats. Others have suggested, however, that this traditional dietary pattern is difficult to adapt to other populations due to differences in cultural and environmental conditions. 48

CONCLUSION

There is ample evidence that diets low in saturated fats and sodium and rich in fruits, vegetables, and fiber, with adequate amounts of potassium, calcium, and magnesium, are effective in the prevention and treatment of hypertension alone or as an adjunct to pharmacologic therapy. Such dietary combinations are provided by the Mediterranean diet.

References

  • 1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey 1988–1999. Hypertension. 1995; 25:305–313. [DOI] [PubMed] [Google Scholar]
  • 2. Palmer A, Bulpitt C, Beevers G, et al. Risk factors for ischemic heart disease and stroke mortality in young and old hypertensive patients. J Hum Hypertens. 1995; 9:695–697. [PubMed] [Google Scholar]
  • 3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560–2572. [DOI] [PubMed] [Google Scholar]
  • 4. World Health Organization Study Group . Diet, Nutrition, and the Prevention of Chronic Diseases. Geneva , Switzerland : World Health Organization; 2003. Technical Report Series, No. 916. [PubMed] [Google Scholar]
  • 5. EUROASPIRE Study Group. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. European Action on Secondary Prevention through Intervention to Reduce Events [erratum in Eur Heart J. 1998;19:356–357]. Eur Heart J. 1997;18:1569–1582. [DOI] [PubMed] [Google Scholar]
  • 6. Appel L, Moore T, Obarzanek E, et al., for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997; 336:1117–1124. [DOI] [PubMed] [Google Scholar]
  • 7. Panagiotakos DB, Pitsavos CH, Chrysohoou C, et al. Status and management of hypertension in Greece: role of the adoption of a Mediterranean diet: the Attica study. J Hypertens. 2003; 21:1483–1489. [DOI] [PubMed] [Google Scholar]
  • 8. Trichopoulou A, Lagiou P. Healthy traditional Mediterranean diet: an expression of culture, history and lifestyle. Nutr Rev. 1997; 55:383–389. [DOI] [PubMed] [Google Scholar]
  • 9. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15‐year death rate in the Seven Countries Study. Am J Epidemiol. 1986; 124:903–915. [DOI] [PubMed] [Google Scholar]
  • 10. Martinez‐Gonzalez MA, Fernandez‐Jarne E, Serrano‐ Martinez M, et al. Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur J Nutr. 2002; 41:153–160. [DOI] [PubMed] [Google Scholar]
  • 11. Trichopoulou A, Lagiou P, Kuper H, et al. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000; 9:869–873. [PubMed] [Google Scholar]
  • 12. Carvalho JJM, Baruzzi RG, Howard PF, et al. Blood pressure in four remote populations in the INTERSALT study. Hypertension. 1989; 14:238–246. [DOI] [PubMed] [Google Scholar]
  • 13. Cutler JA, Follmann D, Elliott P, et al. An overview of randomized trials of sodium reduction and blood pressure. Hypertension. 1991;17(suppl I):I27–I33. [DOI] [PubMed] [Google Scholar]
  • 14. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III‐Analysis of data from trials of salt reduction. BMJ. 1991; 302:819–824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. JAMA. 1992; 267:1213–1220. [DOI] [PubMed] [Google Scholar]
  • 16. Dahl LK, Heine M. Primary role of renal hemografts in setting chronic blood pressure levels in rats. Circ Res. 1975; 36:692–696. [DOI] [PubMed] [Google Scholar]
  • 17. Weir MR, Dengel DR, Belhrens T, et al Salt‐induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension. 1995; 25:1339–1344. [DOI] [PubMed] [Google Scholar]
  • 18. Wyss JM, Oparil S, Sripairojthikoon W. Neuronal control of the kidney: contribution to hypertension. Can J Physiol Pharmacol. 1992; 70:759–770. [DOI] [PubMed] [Google Scholar]
  • 19. Midgley JP, Matthew AG, Greenwood CM, et al. Effects of reduced dietary sodium on blood pressure. JAMA. 1996; 275:1590–1597. [DOI] [PubMed] [Google Scholar]
  • 20. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high‐normal blood pressure . The Trial of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med. 1997; 157:657–667. [PubMed] [Google Scholar]
  • 21. Khaw KT, Barrett‐Connor E. The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation. 1988; 77:53–61. [DOI] [PubMed] [Google Scholar]
  • 22. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta‐analysis of randomized controlled clinical trials. JAMA. 1997; 277:1624–1632. [DOI] [PubMed] [Google Scholar]
  • 23. Joffres MR, Reed DM, Yano K. Relation of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr. 1987; 45:469–475. [DOI] [PubMed] [Google Scholar]
  • 24. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotic arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities study. J Clin Epidemiol. 1995; 48:927–940. [DOI] [PubMed] [Google Scholar]
  • 25. Cappuccio FP, Elliott P, Allender PS, et al. Epidemiologic association between dietary calcium intake and blood pressure: a meta‐analysis of published data. Am J Epidemiol. 1995; 142:935–945. [DOI] [PubMed] [Google Scholar]
  • 26. Morris CD, McCarron DA. Effect of calcium supplementation in an older population with mildly increased blood pressure. Am J Hypertens. 1992; 5:230–237. [DOI] [PubMed] [Google Scholar]
  • 27. Allender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta‐analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825–831. [DOI] [PubMed] [Google Scholar]
  • 28. Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure: a meta‐analysis of randomized controlled trials. JAMA. 1996; 275:1016–1022. [DOI] [PubMed] [Google Scholar]
  • 29. Klatsky AL, Friedman GD, Siegeland AB, et al. Alcohol consumption and blood pressure. Kaiser‐Permanente Multiphasic Health Examination data. N Engl J Med. 1977; 296:1194–1200. [DOI] [PubMed] [Google Scholar]
  • 30. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Risk stratification of coronary heart disease in Greece: final results from the CARDIO2000 epidemiological study. Prev Med. 2002; 35:548–556. [DOI] [PubMed] [Google Scholar]
  • 31. Puddey IB, Beilin LJ, Vandongen R, et al. Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension. 1985; 7:707–713. [DOI] [PubMed] [Google Scholar]
  • 32. McCarron D. Diet and blood pressure‐the paradigm shift. Science. 1998; 281:933–934. [DOI] [PubMed] [Google Scholar]
  • 33. Margetts BM, Beilin LJ, Vandongen R, et al. Vegetarian diet in mild hypertension: a randomized controlled trial. BMJ. 1986; 293:1468–1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 1995; 61:1321S–1323S. [DOI] [PubMed] [Google Scholar]
  • 35. Willett WC, Sacks F, Trichopoulou A, et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995; 61:1402S–1406S. [DOI] [PubMed] [Google Scholar]
  • 36. US Department of Health and Human Services . Dietary guidelines for Americans 2005. Available at: http:www. healthierus.govdietaryguidelines. Accessed February 3, 2005.
  • 37. Panagiotakos DB, Pitsavos C, Polychronopoulos E, et al. Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. Med Sci Monit. 2004; 10:RA193–RA198. [PubMed] [Google Scholar]
  • 38. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al. The adoption of Mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndrome. Nutr J. 2003;2:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003; 348:2599–2608. [DOI] [PubMed] [Google Scholar]
  • 40. Schroder H, Schmelz E, Marrugat J. Relationship between diet and blood pressure in a representative Mediterranean population. Eur J Nutr. 2002; 41:161–167. [DOI] [PubMed] [Google Scholar]
  • 41. Alonso A, de la Fuente C, Martin‐Arnau AM, et al. Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean population with a high vegetable‐fat intake: the Seguimiento Universidad de Navarra (SUN) Study. Br J Nutr. 2004; 92:311–319. [DOI] [PubMed] [Google Scholar]
  • 42. Ruiz‐Gutierrez V, Muriana FJG, Guerrero A. Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J Hypertens. 1996; 14:1483–1490. [DOI] [PubMed] [Google Scholar]
  • 43. Strazullo P, Ferro‐Luzzi A, Siani A, et al. Changing the Mediterranean diet: effects on blood pressure. J Hypertens. 1986; 4:407–412. [DOI] [PubMed] [Google Scholar]
  • 44. Assmann G, de Backer G, Bagnara S, et al. International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev. 1997; 6:418–421. [DOI] [PubMed] [Google Scholar]
  • 45. Simopoulos AP. The Mediterranean diets: What is so special about the diet of Greece? The scientific evidence. J Nutr. 2001; 131:3065S–3073S. [DOI] [PubMed] [Google Scholar]
  • 46. De Lorgeril M, Salen P. Diet as preventive medicine in cardiology. Curr Opin Cardiol. 2000; 15:364–370. [DOI] [PubMed] [Google Scholar]
  • 47. Kouris‐Blazos A, Gnardellis CH, Wahlqvist ML, et al. Are the advantages of the Mediterranean diet transferable to other populations? A cohort study in Melbourne, Australia. Br J Nutr. 1999; 82:57–61. [DOI] [PubMed] [Google Scholar]
  • 48. Robertson RM, Smaha L. Can a Mediterranean‐style diet reduce heart disease? Circulation. 2001; 103:1821–1822. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Hypertension are provided here courtesy of Wiley

RESOURCES